Cargando…
Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank
BACKGROUND: Gamma-glutamyltransferase (GGT) levels in the blood can be a sensitive marker of liver injury but the extent to which they give insight into risk across multiple outcomes in a clinically useful way remains uncertain. METHODS: Using data from 293,667 UK Biobank participants, the relations...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112033/ https://www.ncbi.nlm.nih.gov/pubmed/35706481 http://dx.doi.org/10.1016/j.eclinm.2022.101435 |
_version_ | 1784709341005217792 |
---|---|
author | Ho, Frederick K Ferguson, Lyn D Celis-Morales, Carlos A Gray, Stuart R Forrest, Ewan Alazawi, William Gill, Jason MR Katikireddi, Srinivasa Vittal Cleland, John GF Welsh, Paul Pell, Jill P Sattar, Naveed |
author_facet | Ho, Frederick K Ferguson, Lyn D Celis-Morales, Carlos A Gray, Stuart R Forrest, Ewan Alazawi, William Gill, Jason MR Katikireddi, Srinivasa Vittal Cleland, John GF Welsh, Paul Pell, Jill P Sattar, Naveed |
author_sort | Ho, Frederick K |
collection | PubMed |
description | BACKGROUND: Gamma-glutamyltransferase (GGT) levels in the blood can be a sensitive marker of liver injury but the extent to which they give insight into risk across multiple outcomes in a clinically useful way remains uncertain. METHODS: Using data from 293,667 UK Biobank participants, the relationship of GGT concentrations to self-reported alcohol intake and adiposity markers were investigated. We next investigated whether GGT predicted liver-related, cardiovascular (CV) or all-cause mortality, and potentially improved CV risk prediction. FINDINGS: Higher alcohol intake and greater waist circumference (WC) were associated with higher GGT; the association was stronger for alcohol with evidence of a synergistic effect of WC. Higher GGT concentrations were associated with multiple outcomes. Compared to a GGT of 14.5 U/L (lowest decile), values of 48 U/L for women and 60 U/L for men (common upper limits of ‘normal’) had hazard ratios (HRs) for liver-related mortality of 1.83 (95% CI 1.60–2.11) and 3.25 (95% CI 2.38–4.42) respectively, for CV mortality of 1.21 (95% CI 1.14–1.28) and 1.43 (95% CI 1.27–1.60) and for all-cause mortality of 1.15 (95% CI 1.12–1.18) and 1.31 (95% CI 1.24–1.38). Adding GGT to a risk algorithm for CV mortality reclassified an additional 1.24% (95% CI 0.14–2.34) of participants across a binary 5% 10-year risk threshold. INTERPRETATION: Our study suggests that a modest elevation in GGT levels should trigger a discussion with the individual to review diet and lifestyle including alcohol intake and consideration of formal liver disease and CV risk assessment if not previously done. FUNDING: British Heart Foundation Centre of Research Excellence Grant (grant number RE/18/6/34217), NHS Research Scotland (grant number SCAF/15/02), the Medical Research Council (grant number MC_UU_00022/2); and the Scottish Government Chief Scientist Office (grant number SPHSU17). |
format | Online Article Text |
id | pubmed-9112033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-91120332022-06-14 Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank Ho, Frederick K Ferguson, Lyn D Celis-Morales, Carlos A Gray, Stuart R Forrest, Ewan Alazawi, William Gill, Jason MR Katikireddi, Srinivasa Vittal Cleland, John GF Welsh, Paul Pell, Jill P Sattar, Naveed eClinicalMedicine Articles BACKGROUND: Gamma-glutamyltransferase (GGT) levels in the blood can be a sensitive marker of liver injury but the extent to which they give insight into risk across multiple outcomes in a clinically useful way remains uncertain. METHODS: Using data from 293,667 UK Biobank participants, the relationship of GGT concentrations to self-reported alcohol intake and adiposity markers were investigated. We next investigated whether GGT predicted liver-related, cardiovascular (CV) or all-cause mortality, and potentially improved CV risk prediction. FINDINGS: Higher alcohol intake and greater waist circumference (WC) were associated with higher GGT; the association was stronger for alcohol with evidence of a synergistic effect of WC. Higher GGT concentrations were associated with multiple outcomes. Compared to a GGT of 14.5 U/L (lowest decile), values of 48 U/L for women and 60 U/L for men (common upper limits of ‘normal’) had hazard ratios (HRs) for liver-related mortality of 1.83 (95% CI 1.60–2.11) and 3.25 (95% CI 2.38–4.42) respectively, for CV mortality of 1.21 (95% CI 1.14–1.28) and 1.43 (95% CI 1.27–1.60) and for all-cause mortality of 1.15 (95% CI 1.12–1.18) and 1.31 (95% CI 1.24–1.38). Adding GGT to a risk algorithm for CV mortality reclassified an additional 1.24% (95% CI 0.14–2.34) of participants across a binary 5% 10-year risk threshold. INTERPRETATION: Our study suggests that a modest elevation in GGT levels should trigger a discussion with the individual to review diet and lifestyle including alcohol intake and consideration of formal liver disease and CV risk assessment if not previously done. FUNDING: British Heart Foundation Centre of Research Excellence Grant (grant number RE/18/6/34217), NHS Research Scotland (grant number SCAF/15/02), the Medical Research Council (grant number MC_UU_00022/2); and the Scottish Government Chief Scientist Office (grant number SPHSU17). Elsevier 2022-05-12 /pmc/articles/PMC9112033/ /pubmed/35706481 http://dx.doi.org/10.1016/j.eclinm.2022.101435 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Ho, Frederick K Ferguson, Lyn D Celis-Morales, Carlos A Gray, Stuart R Forrest, Ewan Alazawi, William Gill, Jason MR Katikireddi, Srinivasa Vittal Cleland, John GF Welsh, Paul Pell, Jill P Sattar, Naveed Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank |
title | Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank |
title_full | Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank |
title_fullStr | Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank |
title_full_unstemmed | Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank |
title_short | Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank |
title_sort | association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: a prospective cohort study in the uk biobank |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112033/ https://www.ncbi.nlm.nih.gov/pubmed/35706481 http://dx.doi.org/10.1016/j.eclinm.2022.101435 |
work_keys_str_mv | AT hofrederickk associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT fergusonlynd associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT celismoralescarlosa associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT graystuartr associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT forrestewan associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT alazawiwilliam associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT gilljasonmr associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT katikireddisrinivasavittal associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT clelandjohngf associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT welshpaul associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT pelljillp associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank AT sattarnaveed associationofgammaglutamyltransferaselevelswithtotalmortalityliverrelatedandcardiovascularoutcomesaprospectivecohortstudyintheukbiobank |